← Leaderboards
Susan R Mallery
Ohio State University
$15,292,540
Attributed
$16,099,061
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,099,061 · 13
By mechanism
R01$11,705,085 · 7
T32$1,613,043 · 1
RC2$1,349,227 · 1
R21$793,450 · 2
P01$538,256 · 1
R41$100,000 · 1
Top collaborators
- John F Sheridan3 shared
Most similar at Ohio State University
Same institution · by research overlap
- Michael A Caligiuri$65,062,344
- Steven K Clinton$5,749,067
- Christopher M Weghorst$9,056,160
- Ming You$26,875,453
- Krista Marie Dubray La Perle$1,632,491
Others in their field
Top investigators on “Chemoprevention”
- Charles A Coltman · Southwest Oncology Group$144,723,158
- Norman Wolmark · Nsabp Foundation, Inc.$110,141,959
- John Anthony Baron · Dartmouth College$61,176,184
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Caroline C Sigman · Ccs Associates, Inc.$26,419,788
- Jonathan White · Midwest Research Institute$24,635,824
Research focus
ChemopreventionIn VivoPreventMalignant NeoplasmsAffectChemopreventive AgentGrowthTissuesOperative Surgical ProceduresDrug KineticsExcisionIn VitroSignal TransductionOral LesionPremalignantDoseVitamin ABaseMalignant Mouth NeoplasmMouth Squamous Cell CarcinomaOralSiteMetabolismCessation Of Life
Grant awards (45)
Multidisciplinary Research Training in Dental, Oral, and Craniofacial Sciences (MARTDOCS)$538,697
T32 · FY2025 · DE · contact PI
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention$466,204
R01 · FY2025 · CA · contact PI
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention$723,383
R01 · FY2024 · CA · contact PI
Multidisciplinary Research Training in Dental, Oral, and Craniofacial Sciences (MARTDOCS)$548,967
T32 · FY2024 · DE · contact PI
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions$294,102
R01 · FY2024 · CA · contact PI
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention$583,736
R01 · FY2023 · CA · contact PI
Multidisciplinary Research Training in Dental, Oral, and Craniofacial Sciences (MARTDOCS)$525,379
T32 · FY2023 · DE
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions$475,395
R01 · FY2023 · CA · contact PI
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention$581,591
R01 · FY2022 · CA · contact PI
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions$526,930
R01 · FY2022 · CA · contact PI
Secondary Chemoprevention of Oral Cancer by Locally Delivered Agents$356,255
R01 · FY2021 · CA · contact PI
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions$102,286
R01 · FY2021 · CA · contact PI
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions$689,751
R01 · FY2020 · CA · contact PI
Secondary Chemoprevention of Oral Cancer by Locally Delivered Agents$356,255
R01 · FY2020 · CA · contact PI
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions$706,443
R01 · FY2019 · CA · contact PI
Secondary Chemoprevention of Oral Cancer by Locally Delivered Agents$345,567
R01 · FY2019 · CA · contact PI
Secondary Chemoprevention of Oral Cancer by Locally Delivered Agents$356,114
R01 · FY2018 · CA · contact PI
Secondary Chemoprevention of Oral Cancer by Locally Delivered Agents$366,984
R01 · FY2017 · CA · contact PI
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer$318,056
R01 · FY2016 · CA · contact PI
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer$318,056
R01 · FY2015 · CA · contact PI
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer$308,515
R01 · FY2014 · CA · contact PI
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer$298,972
R01 · FY2013 · CA · contact PI
Chemoprevention of Head & Neck Cancer Using Controlled Release Polymers$283,799
R01 · FY2013 · CA · contact PI
Evaluation of locally-delivered fenretinide and black raspberries for oral cancer$331,181
R01 · FY2012 · CA · contact PI
Chemoprevention of Head & Neck Cancer Using Controlled Release Polymers$301,913
R01 · FY2012 · CA · contact PI
Chemoprevention of Head & Neck Cancer Using Controlled Release Polymers$304,087
R01 · FY2011 · CA · contact PI
Clinical evaluation of a bioadhesive gel for oral cancer chemoprevention.$539,792
RC2 · FY2010 · CA · contact PI
Chemoprevention of Head & Neck Cancer Using Controlled Release Polymers$313,491
R01 · FY2010 · CA · contact PI
Clinical evaluation of a bioadhesive gel for oral cancer chemoprevention.$809,435
RC2 · FY2009 · CA · contact PI
Chemoprevention of Head & Neck Cancer Using Controlled Release Polymers$325,991
R01 · FY2009 · CA · contact PI
Evaluation of bioadhesive berry gels for oral cancer chemoprevention$171,775
R21 · FY2009 · CA · contact PI
Evaluation of bioadhesive berry gels for oral cancer chemoprevention$218,025
R21 · FY2008 · CA · contact PI
Role of Oxidants & Angiogenesis in Kaposi's Sarcoma$285,126
R01 · FY2007 · CA · contact PI
Role of Oxidants & Angiogenesis in Kaposi's Sarcoma$293,642
R01 · FY2006 · CA · contact PI
Formulation & Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention$100,000
R41 · FY2006 · AT · contact PI
Role of Oxidants &Angiogenesis in Kaposi's Sarcoma$311,278
R01 · FY2005 · CA
Chemoprevention of Oral Dysplasia by Black Raspberries$201,825
R21 · FY2005 · CA
Role of Oxidants &Angiogenesis in Kaposi's Sarcoma$262,550
R01 · FY2004 · CA
Chemoprevention of Oral Dysplasia by Black Raspberries$201,825
R21 · FY2004 · CA
Role of Oxidants &Angiogenesis in Kaposi's Sarcoma$262,550
R01 · FY2003 · CA
CARCINOGEN/OXIDANT SYNERGISM IN ORAL CANCER$134,564
P01 · FY2002 · DE
CARCINOGEN/OXIDANT SYNERGISM IN ORAL CANCER$134,564
P01 · FY2002 · DE
CARCINOGEN/OXIDANT SYNERGISM IN ORAL CANCER$134,564
P01 · FY2001 · DE
LESIONAL CHEMOTHERAPEUTIC MANAGEMENT FOR ORAL AIDS-KS$254,882
R01 · FY2000 · DE
CARCINOGEN/OXIDANT SYNERGISM IN ORAL CANCER$134,564
P01 · FY2000 · DE